Stockholder Claims Ocera Therapeutics Withholding Material Info Concerning Merger
December 4, 2017 Ocera Therapeutics, Inc. and its board of directors are facing a proposed class action filed by a shareholder who claims the defendants have chosen to omit material information from a proxy statement filed in connection with a potential merger.